Is antimicrobial citrate lock therapy routinely used, and what precise standing order should I provide to the dialysis unit for catheter lock solution?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antimicrobial Citrate Lock Therapy for Hemodialysis Catheters

Low-concentration citrate (<5%) is a reasonable and increasingly common catheter lock solution that you should consider using, particularly for preventing catheter-related bloodstream infections (CRBSI), though the choice between citrate and heparin remains at clinician discretion according to current guidelines. 1

Is Antimicrobial Citrate Lock Common Practice?

Antimicrobial citrate lock solutions are becoming more widely adopted in dialysis units, though practice varies significantly between facilities. 2, 3

  • KDOQI 2019 guidelines state that the choice between citrate or heparin as a CVC locking solution is based on clinician discretion, as there is inadequate evidence to demonstrate a difference in CVC survival or complications between these solutions. 1

  • However, KDOQI specifically suggests using low-concentration citrate (<5%) to help prevent CRBSI and catheter dysfunction when feasible. 1

  • Evidence shows citrate lock solutions reduce CRBSI rates compared to heparin (0.28 vs 0.91 episodes per 1,000 catheter-days when combined with gentamicin), while maintaining similar catheter patency. 4

  • Citrate offers several clinical advantages: eliminates heparin-associated bleeding complications, improves reliability of INR assays, and provides an effective alternative for patients with heparin-induced thrombocytopenia. 3

Exact Standing Order for Dialysis Unit

Standard Citrate Lock Protocol:

Concentration and Volume:

  • Use 4% sodium citrate or 5% trisodium citrate as the locking solution 2, 3, 5
  • Instill volume per lumen according to catheter manufacturer specifications (typically matching the internal catheter volume) 1

At Dialysis Disconnection (Post-Treatment):

  1. Flush the catheter: After retransfusing patient's blood, close clamps on CVC lumens and bloodlines, then disconnect one bloodline from one CVC lumen 1

  2. Saline flush: Attach a 5-10 mL syringe with 0.9% normal saline to CVC lumen, unclamp CVC, and flush lumen using turbulent flushing technique 1

  3. Instill citrate lock: Remove normal saline syringe, attach syringe with citrate locking solution, and instill the prescribed volume per unit CVC care protocols 1

  4. Secure the catheter: Close clamp on lumen, remove syringe, clean the hub using "scrub-the-hub" protocol with chlorhexidine, and apply sterile Luer lock cap 1

  5. Repeat for second lumen 1

At Dialysis Connection (Pre-Treatment):

  1. Ensure clamps closed: Remove Luer lock cap and clean the hub with chlorhexidine 1

  2. Aspirate lock solution: Attach syringe, unclamp CVC, and aspirate 2-5 mL of blood and citrate locking solution from lumen, then reclamp 1

  3. Optional saline flush: If no resistance felt with aspiration, attach 5-10 mL syringe of 0.9% normal saline and flush lumen using turbulent flushing technique 1

  4. Connect to dialysis circuit and repeat with second port 1

Sample Standing Order Language:

"For all tunneled hemodialysis catheters: Use 4% sodium citrate lock solution at end of each dialysis session. Instill volume per catheter manufacturer specifications (typically 1.5-2 mL per lumen). Follow standard aseptic technique with hub disinfection using chlorhexidine. Aspirate and discard lock solution before initiating next dialysis treatment." 1, 3

Important Clinical Considerations

Antimicrobial lock solutions (including citrate) probably reduce CRBSI per 1,000 catheter-days (RR 0.38,95% CI 0.27-0.53), though evidence certainty is low. 6

  • Non-antibiotic antimicrobial lock solutions like citrate reduce CRBSI for tunneled CVCs specifically (RR 0.60,95% CI 0.40-0.91) but show less benefit for non-tunneled catheters. 6

  • Citrate and heparin demonstrate comparable catheter dysfunction rates (1.11 vs 1.73 per 1,000 catheter-days, not statistically significant). 5

  • Cost savings with citrate are substantial—approximately 85% reduction in locking therapy costs compared to concentrated heparin. 3

Common Pitfall: Do not exceed the internal catheter volume when instilling lock solution, as systemic spillage can cause complications. 2 Always verify catheter-specific fill volumes from manufacturer specifications.

Additional measure for high-risk patients: Consider antimicrobial barrier caps to further reduce CRBSI in high-risk patients or facilities with elevated infection rates. 1, 7

Related Questions

What is the normal citrate excretion range in a 24‑hour urine collection for an adult?
What is the recommended protocol for continuous renal replacement therapy (CRRT) using regional citrate anticoagulation (RCA) in an adult ICU patient without contraindications?
For a 19‑year‑old with type 1 diabetes, weight 86 kg, creatinine 0.74 mg/dL, GFR > 90 mL/min, bicarbonate 17 mmol/L, anion gap 13, currently on metformin 750 mg daily and insulin glargine (Lantus) 15 U at 8 am and 35 U at 8 pm with carbohydrate‑to‑insulin ratios of 1 U per 6 g carbs at breakfast and 1 U per 7 g carbs at lunch/dinner and an insulin‑sensitivity factor of 25 mg/dL per U, and blood glucose values of 184 mg/dL (8 am), 220 mg/dL (noon), 262 mg/dL (5 pm), 237 mg/dL (10 pm), and 97 mg/dL (4 am), what should the morning and evening Lantus doses be and what should the insulin‑sensitivity factor and insulin‑to‑carbohydrate ratios be adjusted to?
What is the clinical significance of a +1 glucose result on a urine dipstick and how should it be evaluated?
For a 19‑year‑old patient with type 1 diabetes weighing 86.2 kg who is currently taking insulin glargine (Lantus) 12 U at 08:00 and 35 U at 20:00 and uses insulin‑to‑carbohydrate ratios of 1 U per 5 g carbs for breakfast and lunch and 1 U per 6 g carbs for dinner, what should the basal Lantus dose and insulin‑to‑carbohydrate ratio be adjusted to?
When is an X‑ray indicated for a finger injury caused by being slammed in a car door?
What is the recommended management for a dialysis catheter that has been exchanged but remains dysfunctional?
What is the recommended dosage of ferrous bisglycinate for treating iron‑deficiency anemia in adults and children?
What is the most significant risk factor for coronary artery disease?
What is the recommended management for a patient with severe acromioclavicular (AC) joint hypertrophic changes and moderate glenohumeral (GH) joint degeneration on shoulder X‑ray?
In a 49‑year‑old man with bladder pain, urinary frequency, occasional sildenafil use, PSA 1.17 ng/mL, and a urine dipstick showing a small amount of blood and trace leukocytes, what are the appropriate next diagnostic and therapeutic steps?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.